FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Novo Nordisk received approval from the Food and Drug Administration for three new indications of Sogroya, a growth hormone.

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. It might be tempting to believe that growth is purely a matter ...

Sleep is often treated as downtime, a passive break between the real business of being awake. But a new study has revealed that sleep is active, essential biology, showing how the brain uses the night ...

The FDA has approved the once-weekly injectable lonapegsomatropin-tcgd (Skytrofa, Ascendis Pharma A/S) for replacing endogenous growth hormone in adults with growth hormone deficiency (GHD), expanding ...